Neo BioMed Services has been engaged, since 2006, in providing expert technical, regulatory compliance and business support services to Small and Mid-Size Pharmaceutical, Biotechnology, Stem Cell, Biologics, Diagnostic, Medical Devices and allied Health Industries including biodefense industries.
Neo BioMed Services believes in quality of service par excellence and is joining hands with national and international consulting agencies in providing support to solutions meeting the strictest regulatory norms. Our associates are proficient in development, implementation and management of diversified manufacturing and supply chain projects involving the integration of scientific principles, regulatory aspects and business requirements and management.
Neo BioMed Services assist the stakeholders to develop cGMP compliant quality products from concept to commercialization, effective Technology Transfer, regulatory submissions, liaisoning and necessary government approvals. Services are focused on cGMP regulated clinical or commercial Active Pharmaceutical Ingredients (APIs), Rx and OTC drug products, Diagnostic products and tools or Medical Devices.
Neo BioMed Services Ltd., based in United Kingdom is a subsidy of its parent company, Neo BioMed Services, having its registered office in New Delhi, India. Neo BioMed Services was founded and incorporated as a partnership firm in 2006 and now governed under the Indian Companies Act 2013.
The Company is providing consultancy and solutions in health related areas. The Company is led by a management team headed by its Chief Executive Officer Dr. Brij M. Gandhi, a scientist and a technocrat with more than 49 years of experience as scientist, science manager and policy administrator with the Government of India.
Since 2006 the Company has been engaged in providing expert technical, regulatory compliance and business support services to Small and Mid-Size industries ranging from Pharmaceutical & Biotechnology firms, Stem Cell & Regenerative Medicine, Biologics, Diagnostic, Medical Devices, Allied Health and bio-defence industries.